BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31027896)

  • 1. Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study.
    Domingo P; Suarez-Lozano I; Gutierrez F; Estrada V; Knobel H; Palacios R; Antela A; Blanco JR; Fulladosa X;
    Nefrologia (Engl Ed); 2019; 39(5):497-505. PubMed ID: 31027896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
    Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
    BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.
    Calza L; Sachs M; Colangeli V; Borderi M; Granozzi B; Malosso P; Comai G; Corradetti V; La Manna G; Viale P
    Clin Exp Nephrol; 2019 Nov; 23(11):1272-1279. PubMed ID: 31327092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy.
    Cristelli MP; Trullàs JC; Cofán F; Rico N; Manzardo C; Ambrosioni J; Bedini JL; Moreno A; Diekmann F; Miro JM;
    Braz J Infect Dis; 2018; 22(3):193-201. PubMed ID: 29782827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia.
    Joshi K; Boettiger D; Kerr S; Nishijima T; Van Nguyen K; Ly PS; Lee MP; Kumarasamy N; Wong W; Kantipong P; Cuong DD; Kamarulzaman A; Choi JY; Zhang F; Chaiwarith R; Ng OT; Kiertiburanakul S; Sim BLH; Merati TP; Yunihastuti E; Ditangco R; Ross J; Pujari S
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1209-1216. PubMed ID: 30246898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
    Mocroft A; Lundgren JD; Ross M; Fux CA; Reiss P; Moranne O; Morlat P; Monforte Ad; Kirk O; Ryom L;
    Lancet HIV; 2016 Jan; 3(1):e23-32. PubMed ID: 26762990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
    Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; ; ; ; ;
    PLoS Med; 2015 Mar; 12(3):e1001809. PubMed ID: 25826420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.
    Achhra AC; Nugent M; Mocroft A; Ryom L; Wyatt CM
    Curr HIV/AIDS Rep; 2016 Jun; 13(3):149-57. PubMed ID: 27130284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    Kooij KW; Vogt L; Wit FWNM; van der Valk M; van Zoest RA; Goorhuis A; Prins M; Post FA; Reiss P;
    J Infect Dis; 2017 Sep; 216(6):622-631. PubMed ID: 28934420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
    Kamkuemah M; Kaplan R; Bekker LG; Little F; Myer L
    Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.
    Quesada PR; Esteban LL; García JR; Sánchez RV; García TM; Alonso-Vega GG; Ferrández JS
    Int J Clin Pharm; 2015 Oct; 37(5):865-72. PubMed ID: 26008219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.
    Mills AM; Schulman KL; Fusco JS; Brunet L; Hsu R; Beyer A; Prajapati G; Mounzer K; Fusco GP
    HIV Med; 2020 May; 21(5):299-308. PubMed ID: 31985887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of tubulopathy and association with renal function loss in HIV-infected patients.
    Lescure FX; Fellahi S; Pialoux G; Bastard JP; Eme AL; Esteve E; Lebrette MG; Guiard-Schmid JB; Capeau J; Ronco P; Costagliola D; Plaisier E
    Nephrol Dial Transplant; 2020 Apr; 35(4):607-615. PubMed ID: 31071216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
    BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal toxicity of long-term therapy with tenofovir in HIV-infected patients.
    Monteagudo-Chu MO; Chang MH; Fung HB; Bräu N
    J Pharm Pract; 2012 Oct; 25(5):552-9. PubMed ID: 22551561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain.
    Knobel H; Domingo P; Suarez-Lozano I; Gutierrez F; Estrada V; Palacios R; Antela A; Blanco JR; Fulladosa X; Refollo E;
    Enferm Infecc Microbiol Clin (Engl Ed); 2019; 37(6):373-379. PubMed ID: 30389268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of renal disease within an urban HIV-infected cohort in northern Italy.
    Calza L; Vanino E; Magistrelli E; Salvadori C; Cascavilla A; Colangeli V; Di Bari MA; Manfredi R; Viale P
    Clin Exp Nephrol; 2014 Feb; 18(1):104-12. PubMed ID: 23712539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal outcomes after up to 8 years of tenofovir exposure in HIV-HBV-coinfected patients.
    Boyd A; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Plaisier E; Lacombe K
    Antivir Ther; 2017; 22(1):31-42. PubMed ID: 27553871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG; Engsig FN; Feldt-Rasmussen B; Kirk O; Kronborg G; Pedersen C; Gerstoft J; Obel N
    Scand J Infect Dis; 2012 Sep; 44(9):689-96. PubMed ID: 22680981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate.
    Dietrich LG; Barceló C; Thorball CW; Ryom L; Burkhalter F; Hasse B; Furrer H; Weisser M; Steffen A; Bernasconi E; Cavassini M; de Seigneux S; Csajka C; Fellay J; Ledergerber B; Tarr PE
    Clin Infect Dis; 2020 Feb; 70(5):890-897. PubMed ID: 30953057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.